Replimune (REPL) Change in Accured Expenses (2017 - 2026)

Replimune has reported Change in Accured Expenses for 10 years, with the latest figure at $6.9 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 25.74% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 81.4% YoY) and the FY2026 annual result came in at $2.2 million, down 81.4% from the prior year.
• Change in Accured Expenses advanced to $6.9 million in Q1 2026 per REPL's latest filing, from -$1.9 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $9.2 million in Q1 2025 and troughed at -$5.5 million in Q2 2025.
• A 5-year average of $2.2 million and a median of $2.8 million in 2025 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses sank 333.99% in 2022, then soared 715.46% in 2024.
• Over 5 years, Change in Accured Expenses stood at $2.8 million in 2022, then slumped by 130.01% to -$854000.0 in 2023, then surged by 715.46% to $5.3 million in 2024, then tumbled by 136.4% to -$1.9 million in 2025, then surged by 458.76% to $6.9 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $6.9 million, -$1.9 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.